CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.
June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural heart procedure in the world using 4-D hologram technology developed by EchoPixel.
Jacob Dutcher, M.D., an interventional cardiologist and director of the structural heart program at CentraCare Heart and Vascular Center, conducted a Watchman transcatheter left atrial appendage (LAA) occluder implant in an atrial fibrillation patient who need an alternative to blood thinners. This new approach to the Watchman procedure combines both EchoPixel’s pre-planning True3D software with its intra-operative Holographic Therapy Guidance (HTG) software platform. By leveraging mixed reality capabilities, EchoPixel brings precision to structural heart procedures by utilizing HTG, a transformative 4-D technology that enables the entire heart team to interact with a patient’s specific organs and tissues as if they were actual, physical objects. These augmented reality technologies reduce procedure time, improve accuracy of the procedure, reduce risk of complication and hasten recovery.
CentraCare Heart and Vascular Center is the first in the world to use EchoPixel’s technology both before and during a structural heart procedure. This technology was first unveiled on the expo floor at TCT 2019.
“EchoPixel pre-planning True3D software helped us reduce our procedure times by more than 27% and increase optimal procedure outcome by 20%. EchoPixel-HTG is taking us to the next level,” Dutcher said. “As one of the world’s largest Watchman implanting sites, we are always looking for new ways to advance and improve patient care, and are proud to be the first center in the world to offer this novel imaging technology.”
“Dr. Dutcher has been very influential in the development and evolution of our HTG technology,” says Sergio Aguirre, CEO of EchoPixel. “Having him on board has helped us hone our device and approach as we draw on his vast experience with this procedure. We are looking forward to continuing to work with him and CentraCare to adapt our software to other structural heart procedures, providing an even greater benefit to patients.”
About CentraCare Heart and Vascular Center
CentraCare Heart and Vascular Center is one of the largest cardiovascular programs in Minnesota, offering the latest advancements in care, technology and treatment. In 2020 U.S. News & World Report rated the program as #41 in the nation for cardiology and heart surgery. It is part of CentraCare, a Minnesota health system that includes eight hospitals in St. Cloud, Long Prairie, Melrose, Monticello, Paynesville, Redwood Falls, Sauk Centre and Willmar. The health system also owns more than 30 clinics along with 18 senior housing facilities and long-term care facilities throughout the region. For more information: www.centracare.com.
About EchoPixel
Headquartered in Silicon Valley, EchoPixel is a venture capital-backed startup and a pioneer in creating the operating room of the future. The company’s technologies include the first pre-operative True3D planning platform and intra-operative Holographic Therapy Guidance (HTC) software, which allow physicians to interact with patient-specific organs and tissues as if they were actual, physical objects. EchoPixel’s True3D software platform has already become the standard of care at world-leading congenital heart defect and structural heart centers. For more information: echopixeltech.com.
Related Augemented Reality Cardiology Technology
6 Hot Topics in Interventional Cardiology at TCT 2019
FDA Clears First Holographic Cardiac Ablation Guidance System
EchoPixel Introduces 3-D Holographic Intraoperative Software
VIDEO: Use of Virtual Reality to Review Structural Heart Imaging Exams
VIDEO: Use of Virtual Reality to Aid Congenital Heart Disease
July 08, 2024 
